Vernon Innovative Publishers are committed to provide easy and valuable publication services. The goal of VIPOA is to promote international scientific community by publishing premium journals to provide subscribers with high quality scientific data .
VIPOA is dedicated to maintain the utmost standard of professional ethics, accuracy and value in all matters allied to handling manuscripts and reporting scientific articles.
Instructions for authors
- Benefits for authors
- Types of articles
- Manuscript preparation and submission
- Additional files preparation
- Competing interests
- Author contributions
- Acknowledgements and funding
- Consent and Ethics
- Clinical trial and Trial registration
- Style and Language
- Online free access of articles
- Stringent/unbiased peer review process within 2-3 weeks
- Low Article processing charges
- Authors without funding facility will be given fee waiver
- Maintains quality & standards of the articles.
- High visibility and promotion of your research work in Social Networking Sites.
- Rapid and efficient publication
We accept the following types :
- Original Articles
- Research Articles
- Review Articles
- Case Reports
- Short Report
- Methodology Articles
SUBMISSION OF MANUSCRIPT :All the manuscripts should be submitted online and you will be directed stepwise execution for uploading your files.
Cover letter :Each new submission should have a cover letter. The cover letter should contain manuscript title, brief description and relevant information towards the scope of the journal and also include complete contact details like office address, telephone number and email address of the corresponding author and all the co-authors if any. Any further additional information such as recommended reviewers or conflict of interest can also be added in the cover letter.
Manuscript preparationGeneral format for preparation of all types of articles.
- Main text
- Tables and Figures
- Preparing additional files
TitleGeneral information regarding an article and its author is presented on the manuscript which includes :
- Concise and Informative title.
- Name(s) of author(s) and author affiliation(s) with complete address (es).
- Corresponding author name (Ensure that phone numbers (with country and area code) are provided in addition to the e-mail address and the complete postal address.
- Avoid abbreviations, acronyms and formulae if possible
- Short version of title (less than 40 letters and spaces).
AbstractThe abstract should provide background for the study, basic procedures, main findings, principal conclusion. The abstract should be not more than 250 -300 words.
KeywordsKindly provide 4 to 10 keywords representing the article content.
- Manuscripts should be submitted in MS word format.
- Use normal, plain font (e.g., 12-point Times New Roman) for text.
- Use italics for emphasis.
- Use the automatic page numbering function.
- Do not use field functions.
- Use tab stops or other commands for indents and not the space bar.
- Use the table function instead of spreadsheets to make tables.
- Use the equation editor or Math Type for equations.
VIPOA Journals uses the numbered citation (citation-sequence) method. References are listed and numbered in the order that they appear in the text. In the text, citations should be indicated by the reference number in brackets. Multiple citations within a single set of brackets should be separated by comma and where there are three or more sequential citations, they should be given as a range. Example: "... now enable biologists to simultaneously monitor the expression of thousands of genes in a single experiment [1,5-7,28]." Make sure the parts of the manuscript are in the correct order for the relevant journal before ordering the citations. Authors are requested to provide at least one online link for each reference (preferably PubMed). Because all references will be linked electronically as much as possible to the papers they cite, proper formatting of the references is mandatory.
Please use the following style for the reference list :
Fisman, D. N. (2000). Hemophagocytic syndromes and infection. Emerg Infect Dis, 6, 601-8.
Article in Press
Fisman, D. N. (2000). Hemophagocytic syndromes and infection. Emerg Infect Dis, 6, 601-8.
Author details (surname and initial(s)).(Year). "Chapter Title" (in Regular). Details of Edition (if any), Title of the Book (in Italic). page no's
Janka, Gritta and Udo Zur Stadt. (2005). "Familial and acquiredhemophagocytic lymphohistiocytosis." ASH Education Program Book, 1, 82-88
Author details (surname and initial(s)). Title. Name of the website Year. Available at : [URL]
Ex: Gorge,K. Destruction of Ozone. National Institute of Nutrition 2010. Available at : [http://www.ninindia.org ]
Author details (surname and initial(s)) : Title of the News. Name of the news paper Dated.
Ex: John, K. Biomolecules for treating municipal waste. USA Today 22-Dec-2011.
Web links and URLs should be included in the reference list. They should be provided in full, including both the title of the site and the URL
Example: The Mouse Tumor Biology Database [http://tumor.informatics.jax.org/mtbwi/index.do].
If an author or group of authors is associated with a web link, such as for weblogs, then they should be included in the reference.
- Use only Arabic numerals in all tables.
- Always cite the tables in the text in consecutive numerical order.
- For each table, please supply a table caption (title) explaining the components of the table.
- If you use data from another published or unpublished source, obtain permission and acknowledge that source fully.
- Footnotes to tables should be indicated by superscript lower-case letters (or asterisks for significance values and other statistical data) and included beneath the table body.
The figures and their legends should be clear, simple and make available in a separate file or at the end of the manuscript. The acceptable format for figures are PDF, doc, JPEG, TIFF, PowerPoint, BMP, etc. Unnecessary figures and parts (panels) of figures should be avoided. All figures should be cited in the paper in a consecutive order like fig.1,fig.2. When symbols, arrows, numbers or letters are used in figures to identify parts of the illustrations and explain each one clearly in the legend.
Abbreviations should be clearly spelled out in the text for the first time and used consistently thereafter.
Although Journal title does not imply any restrictions on the length of data in a paper, but still authors may wish to provide data sets, tables, movie files, or other information as additional information. These files can be uploaded using the "upload files" button in the manuscript submission process. The maximum file size for additional files is 20 MB each and files will be virus-scanned on submission. Any additional files will be linked into the final published article in the form supplied by the author, but will not be displayed within the paper. They will be made available in exactly the same form as originally provided.
Authors should mention the following information for all additional material at the end of the document in a separate section :
- File name
- File format (include correct file extension and a URL of an appropriate viewer if format is unusual)
- Title of data
- Description of data
Additional data files should be referenced clearly by file name within the text of the article, e.g. 'See additional file 1: Movie1 for the original data used to perform this analysis'.
ADDITIONAL FILE FORMATS
Preferably, additional files should be in usual file formats performing on widely usable and available tools and platforms. Avoid platform-specific file formats. The following are examples of suitable formats.
Additional documentation : PDF (Adobe Acrobat)
Animations : SWF (Shockwave Flash)
Movies : MOV (QuickTime), MPG (MPEG), Tabular data, XLS (Excel spreadsheet), CSV (Comma separated values)
Competing interests can take the form of both financial and non-financial relationships. So, authors must declare and provide the competing interests section at the end of the manuscript.
Examples for financial and non-financial competing interests:
- Receipt in any form of an organisation or individual related to the subject matter.
- Ownership of stocks or shares in organisations directly related to the subject matter.
- Receipt of grants or funding.
- Membership of relevant boards.
- Related patents/applied for patents.
- Known relationships that will hinder impartiality (e.g. colleagues, family, mentor, previous supervisor/student).
- Political, religious, ideological interests.
Competing interests should generally be declared to cover at least the previous 5 years. This is a minimum requirement and individuals must declare if they had a previous relationship with someone or an organization relevant to the submission that could be deemed to influence decision making.
- In order to give appropriate credit to each author for their participation in designing the work, conducting experimental procedures, validations, data acquisition, compilation, analysis and interpretation are specified in this section.
- According to ICMJE guidelines, All contributors should meet the criteria :
- Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work.
- Drafting the work or revising it critically for important intellectual content.
- Final approval of the version to be published.
People contributing towards the work in any other way than a potential author for the manuscript preparation, should be listed in acknowledgements section mentioning their contributions. It is recommended to acknowledge the funding source(s) and describe the involvement of funding body or organization in the whole work. Permissions should be granted by all who are acknowledged in this section.
While reporting the studies on human subjects, indicate whether the procedures followed have been approved by an Ethics committee (in accordance with ethical standards on human experimentation and with the Helsinki Declaration of 1975, as revised in 1983). Do not use patients' names, initials, or hospital numbers, especially in illustrative material. Identifying information should not be published in written descriptions, photographs and pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. Informed consent for this purpose requires that the patient be shown the manuscript to be published.
The ICMJE defines a clinical trial as any research project that prospectively assigns people or a group of people to an intervention, with or without concurrent comparison or control groups, to study the cause-and-effect relationship between a health-related intervention and a health outcome. Health-related interventions are those used to modify a biomedical or health-related outcome; examples include drugs, surgical procedures, devices, behavioural treatments, educational programs, dietary interventions, quality improvement interventions and process-of-care changes. Health outcomes are any biomedical or health-related measures obtained in patients or participants, including pharmacokinetic measures and adverse events.
If your original article reports the results of a controlled health care intervention, please list your trial registry, along with the unique identifying number.
Example: Trial registration: Current Controlled Trials ISRCTN61362816. Please note that there should be no space between the letters and numbers of your trial registration number.
VIPOA accept manuscripts written only in English. Spelling should be US English or British English, but not a mixture. Gene, scientific names should be in italic, but protein products should be in plain type. There are no frontiers on the length of articles submitted, but authors are encouraged to be concise for the interest of readers. There is no restriction on the number of figures, tables or additional files that can be included with each article online. Figures and tables should be sequentially referenced. Authors should include all relevant supporting data with each article. VIPOA will not edit submitted manuscripts for style or language; reviewers may advise rejection of a manuscript if it is compromised by grammatical errors. Authors are advised to write admissible and to be checked by co-authors (if any) before submission. In-house copyediting will be minimal. Non-native speakers of English may choose to make use of a copyediting service.
Please ensure that all special characters used are embedded in the text, otherwise they will be lost during conversion to PDF.
Genes, mutations, genotypes and alleles should be indicated in italics and authors are required to use approved gene symbols, names and formatting. Protein products should be in plain type.
Proofs of manuscript will be sent to all authors for minor corrections and approval.
For reprints, authors are requested to contact through email. At which time an estimated cost of the reprints will be furnished. Actual cost can only be provided after publication, as this depends on the length of the article. No reprints will be provided when they are requested after this.
According to VIPOA online copyright and license policies (Creative Commons License 4.0) the authors are copyright holders for all articles in VIP Online (Journal Name) and have granted the right to reuse, reproduce or disseminate the article.